Febuxostat
urate-lowering agent · disease-modifying gout treatment
Nothing to addBy the Layer Nutrition editorial team · How the atlas classifies the 664 molecules
What this medicine is for
Febuxostat belongs to the 'urate-lowering agent (long-term gout treatment)' category. This medicine lowers the level of uric acid to prevent gout attacks.
In the case of Febuxostat, this means: Reduces the level of uric acid. It is most often a maintenance treatment, taken at regular times over long periods; its benefit is judged over time, not by how you feel on the day.
Under which brands it is found
In France, about 11 reimbursable presentations containing Febuxostat are recorded. It comes under various trade names and in generic form.
- Adenuric
- Febuxostat Almus
- Febuxostat Biogaran
- Febuxostat Eg
- Febuxostat Evolugen
- Febuxostat Sandoz
- Febuxostat Teva Sante
- Febuxostat Viatris
- and other presentations
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
Nothing to add here. Febuxostat falls under none of our products, and no single-ingredient supplement is credibly warranted as support. Rather than placing a product on principle, we leave this page without a purchase recommendation. If you are otherwise on a statin, an antidiabetic, a PPI, a contraceptive or a beta-blocker, that is where we can be useful.
Related molecules
To explore in the « Pain and inflammation » family and its neighbours.
See the whole « Pain and inflammation » family · Back to the atlas